Telbivudine contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Telbivudine}} {{CMG}} ==Contraindications== Combination of Tyzeka with pegylated interferon alfa-2a is contraindicated because of increased risk of peripheral neu...")
(No difference)

Revision as of 19:48, 31 December 2013

Telbivudine
TYZEKA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Contraindications

Combination of Tyzeka with pegylated interferon alfa-2a is contraindicated because of increased risk of peripheral neuropathy [see Warnings and Precautions (5.4) and Drug Interactions (7)].[1]


References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.